CANF
Can-Fite BioPharma
CANF
CANF
12 hedge funds and large institutions have $2.43M invested in Can-Fite BioPharma in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.45M | |
| 2 | +$189K | |
| 3 | +$155K | |
| 4 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
+$50K |
| 5 |
Morgan Stanley
New York
|
+$19.7K |
Top Sellers
| 1 | -$91K | |
| 2 | -$88K | |
| 3 | -$44K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$23K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$18K |